News
Blog: IVD product development process from A to Z
Do you wish to experience our work in IVD product development from the first moment of contact to the realization of your end product? We open our doors for you to witness the procedures and processes, who participate in these processes and our commitment to working according to laws and regulations.
Vacancy: HR Manager
De inschrijftermijn voor de HR Manager vacature is gesloten en de ingekomen sollicitaties worden momenteel beoordeeld.
Blog: The importance of good products and skilled experts
We choose to be transparent and like to share our knowledge with you. Only by showing how we work and think we can offer you a solid partnership. For this reason we created several blogs about subjects from our daily practice. Our professionals will give you insight into our processes and methods to help your business succeed in cooperating with Future Diagnostics.
Future Diagnostics Enters Agreement with DIAsource Immunoassays for Free 25OH Vitamin D ELISA product
DIAsource Immunoassays (Louvain-la-Neuve, Belgium), a BioVendor group company, has entered into a strategic agreement with Future Diagnostics (Wijchen, The Netherlands) under which Future Diagnostics will transfer all assets, with the exclusion of IP, related to Free 25OH Vitamin D ELISA product to DIAsource, securing its continued production and sales.
Update on SARS-CoV-2 from Future Diagnostics
We hope that everyone is remaining healthy during the SARS-CoV-2 outbreak. At Future Diagnostics, we work on tomorrow’s healthcare projects. That is what makes our work interesting. Especially at this time when healthcare is being challenged like this.
Top 10 IVD Solution Provider in Europe – 2020
We are very proud that Future Diagnostics Solutions is recognized by MedTech Outlook Magazine as TOP 10 In Vitro Diagnostic Solution Provider in Europe – 2020.
PhD promotion Giuliana Ascone – Euroclast
Future Diagnostics is proudly announcing the PhD promotion of Giuliana Ascone. Giuliana was ESR in the Marie Curie Euroclast project supported by Future Diagnostics and working at the Department of Experimental Rheumatology of the Radboud University.
Successful FDA inspection at Future Diagnostics
Future Diagnostics Solutions B.V. is proud to announce the successful completion of its fifth Food and Drug Administration (FDA) inspection last month. The FDA is responsible for protecting the public health by ensuring the safety, efficacy, and security of human and veterinary drugs, biological products, and medical devices.